Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GeneDx Holdings (WGS)
NASDAQ:WGS
Holding WGS?
Track your performance easily
WGS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.85 - $98.87
Previous CloseN/A
Volume338.68K
Average Volume (3M)698.71K
Market Cap
$1.88B
Enterprise Value$1.15B
Total Cash (Recent Filing)$108.13M
Total Debt (Recent Filing)$39.75M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Feb 18, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.17
Shares Outstanding27,471,397
10 Day Avg. Volume1,063,044
30 Day Avg. Volume698,714
Standard Deviation0.39
R-Squared0.08
Alpha0.00819
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.02
Price to Cash Flow (P/CF)-106.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue4.37
Enterprise Value/Gross Profit12.79
Enterprise Value/Ebitda-12.16
Forecast
1Y Price Target
$96.00Price Target Upside38.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
GeneDx Holdings News
PremiumCompany Announcements
GeneDx Holdings Expects Strong 2024 Financial PerformancePremiumCompany Announcements
GeneDx Holdings Appoints Bryan Dechairo as COO
Ownership Overview
61.77% Insiders
4.65% Mutual Funds
1.03% Other Institutional Investors
26.40% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WGS FAQ
What was GeneDx Holdings’s price range in the past 12 months?
GeneDx Holdings lowest stock price was $2.85 and its highest was $98.87 in the past 12 months.
What is GeneDx Holdings’s market cap?
GeneDx Holdings’s market cap is $1.88B.
When is GeneDx Holdings’s upcoming earnings report date?
GeneDx Holdings’s upcoming earnings report date is Feb 18, 2025 which is in 31 days.
How were GeneDx Holdings’s earnings last quarter?
GeneDx Holdings released its earnings results on Oct 29, 2024. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of -$0.215 by $0.255.
Is GeneDx Holdings overvalued?
According to Wall Street analysts GeneDx Holdings’s price is currently Undervalued.
Does GeneDx Holdings pay dividends?
GeneDx Holdings does not currently pay dividends.
What is GeneDx Holdings’s EPS estimate?
GeneDx Holdings’s EPS estimate is 0.11.
How many shares outstanding does GeneDx Holdings have?
GeneDx Holdings has 27,471,397 shares outstanding.
What happened to GeneDx Holdings’s price movement after its last earnings report?
GeneDx Holdings reported an EPS of $0.04 in its last earnings report, beating expectations of -$0.215. Following the earnings report the stock price went up 49.875%.
Which hedge fund is a major shareholder of GeneDx Holdings?
Among the largest hedge funds holding GeneDx Holdings’s share is Corvex Management LP. It holds GeneDx Holdings’s shares valued at 105M.
---
GeneDx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$96.00 (38.17% Upside)
$96.00 (38.17% Upside)
Blogger Sentiment
Bullish
WGS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 322.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $78.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 20.1%
Last 30 Days ▲ 20.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1798.36%
12-Months-Change
Fundamentals
Return on Equity
-36.40%
Trailing 12-Months
Asset Growth
-2.02%
Trailing 12-Months
Company Description
GeneDx Holdings
CM Life Sciences Inc is a blank check company.
---
WGS Company Deck
---
WGS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant revenue growth, improved profitability, and expansion in key market segments such as exome and genome testing. Despite challenges such as weather impacts and ongoing reimbursement issues, the company is well-positioned for future growth.Read More>---
WGS Revenue Breakdown
96.59% Diagnostic test revenue
3.41% Other
---
WGS Stock 12 Month Forecast
Average Price Target
$96.00
▲(38.17% Upside)
Technical Analysis
Myriad Genetics
―
Pacific Biosciences
―
Guardant Health
―
Natera
―
Exact Sciences
―
Nephros
―
Best Analysts Covering WGS
1 Year
1 Year Success Rate
10/18 ratings generated profit
1 Year Average Return
+168.33%
reiterated a buy rating 3 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +168.33% per trade.
---